🔗 Share this article

Treasury head Reeves has announced she is preparing "specific action to address household expense issues" in the upcoming financial statement.

In comments to the BBC, she emphasized that reducing inflation is a joint duty of both the government and the central bank.

The United Kingdom's inflation rate is expected to be the most elevated among the Group of Seven advanced economies this year and the following year.

Potential Energy Bill Interventions

It is understood the administration could intervene to reduce utility costs, for example by slashing the current 5% level of VAT applied on energy supplies.

A further possibility is to lower some of the government charges currently added to bills.

Fiscal Limitations and Expert Expectations

The administration will obtain the next assessment from the independent fiscal watchdog, the Office for Budget Responsibility, on Monday, which will show how much space there is for these actions.

The view from most experts is that Reeves will have to announce higher taxes or spending cuts in order to adhere to her declared debt limits.

Earlier on Thursday, analysis suggested there was a twenty-two billion pound deficit for the Treasury chief to address, which is at the lower end of forecasts.

"There's a joint job between the central bank and the government to continue tackling some of the drivers of inflation," Reeves informed reporters in Washington, at the annual meetings of the International Monetary Fund and global financial institution.

Tax Commitments and International Issues

While much of the focus has been on expected tax rises, the chancellor said the most recent data from the fiscal watchdog had not altered her pledge to campaign commitments not to increase rates on earnings tax, sales tax or social security contributions.

She blamed an "uncertain global environment" with growing geopolitical and commercial tensions for the fiscal revenue measures, probably to be focused on those "with the broadest shoulders."

Global Trade Disputes

Referring to worries about the UK's commercial links with China she said: "The UK's national security always take priority."

Last week's declaration by Chinese authorities to increase trade restrictions on rare earths and other materials that are essential for advanced tech production led American leader the US President to suggest an additional 100% tariff on goods from China, raising the prospect of an full-scale trade war between the two largest economies.

The US Treasury Secretary called China's action "commercial pressure" and "a global supply chain control attempt."

Inquired about considering the US offer to join its dispute with the Asian nation, the Chancellor said she was "deeply worried" by China's actions and urged the Beijing authorities "to avoid restrictions and limit trade."

She said the decision was "bad for the world economy and generates further challenges."

"It is my opinion there are fields where we must confront Chinese policies, but there are also significant opportunities to trade with China's economy, including financial services and other areas of the economy. We've got to achieve that balance appropriate."

The Treasury chief also confirmed she was working with international partners "on our own essential resources plan, so that we are less reliant."

Health Service Medicine Pricing and Funding

Reeves also acknowledged that the price the NHS spends on drugs could increase as a consequence of ongoing talks with the Trump administration and its pharmaceutical firms, in exchange for reduced taxes and investment.

A number of the biggest global drug companies have said in recent statements that they are either pausing or canceling operations in the United Kingdom, with several blaming the insufficient payments they are receiving.

Last month, the government science advisor said the price the NHS spends on drugs would have to go up to stop companies and drug research funding departing from the United Kingdom.

The Chancellor told media: "It has been observed as a result of the cost structure, that clinical trials, recent pharmaceuticals have not been offered in the UK in the extent that they are in other European countries."

"The objective is to guarantee that individuals getting care from the NHS are can obtain the best critical treatments in the world. And so we are reviewing this situation, and... looking to obtain more funding into the UK."